| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protagonist Therapeutics, Inc. (PTGX) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. PTGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 523.5K | $60.22M | - | |
| Other | 106.8K | $12.28M | - | |
| CFO | 60.8K | $6.99M | - | |
| Dir | 7.8K | $900.1K | - | |
| Dir | 7.8K | $900.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2016 | Lv Management Group, LLC | 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +38.5% |